Accueil /
Tech /
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
📡
Tech
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
··17 vues
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Commentaires (0)
Aucun commentaire pour le moment. Soyez le premier à réagir.
Laisser un commentaire